FI70223C - Foerfarande foer framstaellning av vindesinmonosulfat - Google Patents

Foerfarande foer framstaellning av vindesinmonosulfat Download PDF

Info

Publication number
FI70223C
FI70223C FI793065A FI793065A FI70223C FI 70223 C FI70223 C FI 70223C FI 793065 A FI793065 A FI 793065A FI 793065 A FI793065 A FI 793065A FI 70223 C FI70223 C FI 70223C
Authority
FI
Finland
Prior art keywords
vindesine
sulfuric acid
added
acetonitrile
aqueous sulfuric
Prior art date
Application number
FI793065A
Other languages
English (en)
Finnish (fi)
Other versions
FI793065A (fi
FI70223B (fi
Inventor
Stanislaw Rolski
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI793065A publication Critical patent/FI793065A/fi
Publication of FI70223B publication Critical patent/FI70223B/fi
Application granted granted Critical
Publication of FI70223C publication Critical patent/FI70223C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
FI793065A 1978-10-10 1979-10-03 Foerfarande foer framstaellning av vindesinmonosulfat FI70223C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94959578A 1978-10-10 1978-10-10
US94959578 1978-10-10

Publications (3)

Publication Number Publication Date
FI793065A FI793065A (fi) 1980-04-11
FI70223B FI70223B (fi) 1986-02-28
FI70223C true FI70223C (fi) 1986-09-15

Family

ID=25489302

Family Applications (1)

Application Number Title Priority Date Filing Date
FI793065A FI70223C (fi) 1978-10-10 1979-10-03 Foerfarande foer framstaellning av vindesinmonosulfat

Country Status (32)

Country Link
EP (1) EP0009996B1 (de)
JP (1) JPS5553295A (de)
KR (1) KR850000150B1 (de)
AR (1) AR225153A1 (de)
AT (1) AT370422B (de)
AU (1) AU525702B2 (de)
BE (1) BE879213A (de)
BG (1) BG34763A3 (de)
CA (1) CA1114817A (de)
CH (2) CH645120A5 (de)
CS (1) CS235503B2 (de)
DD (1) DD146461A5 (de)
DE (1) DE2964913D1 (de)
DK (1) DK146823C (de)
EG (1) EG14140A (de)
ES (1) ES484827A1 (de)
FI (1) FI70223C (de)
FR (1) FR2438659A1 (de)
GB (1) GB2031893B (de)
GR (1) GR72394B (de)
HU (1) HU180744B (de)
IE (1) IE48958B1 (de)
IL (1) IL58390A (de)
LU (1) LU81763A1 (de)
MY (1) MY8500569A (de)
NZ (1) NZ191744A (de)
PH (1) PH16092A (de)
PL (1) PL117678B1 (de)
PT (1) PT70269A (de)
RO (1) RO77380A (de)
YU (1) YU241179A (de)
ZA (1) ZA795268B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4558053A (en) * 1983-12-21 1985-12-10 Eli Lilly And Company Naphthalene-1,5-disulfonate salts of dimeric indole-dihydroindole alkaloids
CN112592357B (zh) * 2020-12-22 2022-03-22 海南长春花药业有限公司 一种硫酸长春地辛的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
GR69783B (de) * 1976-09-08 1982-07-07 Lilly Co Eli

Also Published As

Publication number Publication date
KR830001282A (ko) 1983-04-30
CH645120A5 (fr) 1984-09-14
GB2031893A (en) 1980-04-30
FR2438659B1 (de) 1983-03-18
AT370422B (de) 1983-03-25
FI793065A (fi) 1980-04-11
KR850000150B1 (ko) 1985-02-28
FI70223B (fi) 1986-02-28
FR2438659A1 (fr) 1980-05-09
IE48958B1 (en) 1985-06-26
RO77380A (ro) 1981-11-04
DE2964913D1 (en) 1983-03-31
GR72394B (de) 1983-11-01
CS235503B2 (en) 1985-05-15
AR225153A1 (es) 1982-02-26
DD146461A5 (de) 1981-02-11
IE791914L (en) 1980-04-10
GB2031893B (en) 1983-03-30
DK146823B (da) 1984-01-16
AU5142779A (en) 1980-04-17
YU241179A (en) 1983-01-21
DK422979A (da) 1980-04-11
PH16092A (en) 1983-06-20
PL218756A1 (de) 1980-06-16
MY8500569A (en) 1985-12-31
BG34763A3 (en) 1983-11-15
IL58390A0 (en) 1980-01-31
LU81763A1 (fr) 1980-01-24
CH649301A5 (fr) 1985-05-15
EP0009996B1 (de) 1983-02-23
EG14140A (en) 1983-09-30
JPS628119B2 (de) 1987-02-20
AU525702B2 (en) 1982-11-25
DK146823C (da) 1984-07-02
IL58390A (en) 1982-07-30
PL117678B1 (en) 1981-08-31
ATA658279A (de) 1982-08-15
NZ191744A (en) 1981-05-29
ES484827A1 (es) 1980-10-01
BE879213A (fr) 1980-04-08
HU180744B (en) 1983-04-29
JPS5553295A (en) 1980-04-18
EP0009996A1 (de) 1980-04-16
CA1114817A (en) 1981-12-22
ZA795268B (en) 1981-05-27
PT70269A (de) 1979-11-01

Similar Documents

Publication Publication Date Title
US5180722A (en) 10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
KR101154351B1 (ko) 암 치료를 위한 벤조퀴논-함유 안사마이신의 유사체
KR0180245B1 (ko) 10,11-메틸렌디옥시-20(rs)-캠프토테신 및 10,11-메틸렌디옥시-20(s)-캠프토테신 동족체
US5340817A (en) Method of treating tumors with anti-tumor effective camptothecin compounds
JPH04504845A (ja) タキソール誘導体、その薬剤組成物および調製法
EP0116208A1 (de) Mitomycin-Analoge
WO2020156189A1 (zh) 喜树碱衍生物及其水溶性前药、包含其的药物组合物及其制备方法和用途
FI70223C (fi) Foerfarande foer framstaellning av vindesinmonosulfat
FI66866C (fi) Foerfarande foer framstaellning av antiproliferativa 2,4-diamino-6-(dialkoxibensyl)pyrido(2,3-d)pyrimidiner
DE60022095T2 (de) Camptothecin-beta-alanin-ester mit topoisomerase i hemmung
US7601732B2 (en) Crystalline form of 5(S)-(2-hydroxyethoxy)-20(S)-camptothecin
FI71319C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbart vicaminsackarinat
US4259242A (en) Method of preparing vindesine sulfate
JP2000513716A (ja) タキサン誘導体、その調製、及びそれを含有する処方物
WO1991004260A2 (en) 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
US20080255080A1 (en) Hydroquinone Ansamycin Formulations
US4279916A (en) Method of treatment using new leurosine derivatives
WO2004083215A9 (en) Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
JP2003506332A (ja) 経口投与活性のあるビス白金錯体
US4514330A (en) Carbon-7-substituted atinomycin D analogue
Filer et al. Isoquinolines. 6. Potential central nervous system antitumor agents. Nitrogen mustards of 3-amino-4-(p-aminophenyl) isoquinoline
KR100390767B1 (ko) 아지리디닐퀴놀린디온 유도체와 그의 제조방법
KR100344099B1 (ko) 신규한비페닐디카르복실산유도체와이의제조방법
EP0147152A2 (de) Salze von dimeren Indol-dihydroindol-Alkaloiden
KR20240062104A (ko) 교모세포종 약물내성 극복을 위한 테모졸로마이드 유사 항암제

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ELI LILLY AND COMPANY